Global and United States Telmisartan Market Insights, Forecast to 2026

Publisher Name :
Date: 03-Sep-2020
No. of pages: 148
Inquire Before Buying

Telmisartan market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Telmisartan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Telmisartan market is segmented into

- Injection

- Freeze-Dried Powder

Segment by Application, the Telmisartan market is segmented into

- Hospital Use

- Clinic Use

- Others

Regional and Country-level Analysis

The Telmisartan market is analysed and market size information is provided by regions (countries).

The key regions covered in the Telmisartan market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Telmisartan Market Share Analysis

Telmisartan market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Telmisartan business, the date to enter into the Telmisartan market, Telmisartan product introduction, recent developments, etc.

The major vendors covered:

- Pfizer

- Teva

- Boehringer Ingelheim

- Novartis

- Mylan

- Reddy's Laboratories (UK)

- Hema Pharmaceuticals Pvt

- Bayer

- GSK

- Astellas Pharma Inc

- Nippon Boehringer Ingelheim

- Abbott

- Takeda

- Beijing Wansheng Pharmaceutical

Global and United States Telmisartan Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Telmisartan Product Introduction
1.2 Market Segments
1.3 Key Telmisartan Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Telmisartan Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Freeze-Dried Powder
1.5 Market by Application
1.5.1 Global Telmisartan Market Size Growth Rate by Application
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Telmisartan Market Size, Estimates and Forecasts
2.1.1 Global Telmisartan Revenue 2015-2026
2.1.2 Global Telmisartan Sales 2015-2026
2.2 Global Telmisartan, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Telmisartan Historical Market Size by Region (2015-2020)
2.3.1 Global Telmisartan Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Telmisartan Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Telmisartan Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Telmisartan Sales Forecast by Region (2021-2026)
2.4.2 Global Telmisartan Revenue Forecast by Region (2021-2026)
3 Global Telmisartan Competitor Landscape by Players
3.1 Global Top Telmisartan Sales by Manufacturers
3.1.1 Global Telmisartan Sales by Manufacturers (2015-2020)
3.1.2 Global Telmisartan Sales Market Share by Manufacturers (2015-2020)
3.2 Global Telmisartan Manufacturers by Revenue
3.2.1 Global Telmisartan Revenue by Manufacturers (2015-2020)
3.2.2 Global Telmisartan Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Telmisartan Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Telmisartan Revenue in 2019
3.2.5 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Telmisartan Price by Manufacturers
3.4 Global Telmisartan Manufacturing Base Distribution, Product Types
3.4.1 Telmisartan Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Telmisartan Product Type
3.4.3 Date of International Manufacturers Enter into Telmisartan Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Telmisartan Market Size by Type (2015-2020)
4.1.1 Global Telmisartan Sales by Type (2015-2020)
4.1.2 Global Telmisartan Revenue by Type (2015-2020)
4.1.3 Telmisartan Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Telmisartan Market Size Forecast by Type (2021-2026)
4.2.1 Global Telmisartan Sales Forecast by Type (2021-2026)
4.2.2 Global Telmisartan Revenue Forecast by Type (2021-2026)
4.2.3 Telmisartan Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Telmisartan Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Telmisartan Market Size by Application (2015-2020)
5.1.1 Global Telmisartan Sales by Application (2015-2020)
5.1.2 Global Telmisartan Revenue by Application (2015-2020)
5.1.3 Telmisartan Price by Application (2015-2020)
5.2 Telmisartan Market Size Forecast by Application (2021-2026)
5.2.1 Global Telmisartan Sales Forecast by Application (2021-2026)
5.2.2 Global Telmisartan Revenue Forecast by Application (2021-2026)
5.2.3 Global Telmisartan Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Telmisartan Market Size YoY Growth 2015-2026
6.1.1 United States Telmisartan Sales YoY Growth 2015-2026
6.1.2 United States Telmisartan Revenue YoY Growth 2015-2026
6.1.3 United States Telmisartan Market Share in Global Market 2015-2026
6.2 United States Telmisartan Market Size by Players (International and Local Players)
6.2.1 United States Top Telmisartan Players by Sales (2015-2020)
6.2.2 United States Top Telmisartan Players by Revenue (2015-2020)
6.3 United States Telmisartan Historic Market Review by Type (2015-2020)
6.3.1 United States Telmisartan Sales Market Share by Type (2015-2020)
6.3.2 United States Telmisartan Revenue Market Share by Type (2015-2020)
6.3.3 United States Telmisartan Price by Type (2015-2020)
6.4 United States Telmisartan Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Telmisartan Sales Forecast by Type (2021-2026)
6.4.2 United States Telmisartan Revenue Forecast by Type (2021-2026)
6.4.3 United States Telmisartan Price Forecast by Type (2021-2026)
6.5 United States Telmisartan Historic Market Review by Application (2015-2020)
6.5.1 United States Telmisartan Sales Market Share by Application (2015-2020)
6.5.2 United States Telmisartan Revenue Market Share by Application (2015-2020)
6.5.3 United States Telmisartan Price by Application (2015-2020)
6.6 United States Telmisartan Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Telmisartan Sales Forecast by Application (2021-2026)
6.6.2 United States Telmisartan Revenue Forecast by Application (2021-2026)
6.6.3 United States Telmisartan Price Forecast by Application (2021-2026)
7 North America
7.1 North America Telmisartan Market Size YoY Growth 2015-2026
7.2 North America Telmisartan Market Facts & Figures by Country
7.2.1 North America Telmisartan Sales by Country (2015-2020)
7.2.2 North America Telmisartan Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Telmisartan Market Size YoY Growth 2015-2026
8.2 Europe Telmisartan Market Facts & Figures by Country
8.2.1 Europe Telmisartan Sales by Country
8.2.2 Europe Telmisartan Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Telmisartan Market Size YoY Growth 2015-2026
9.2 Asia Pacific Telmisartan Market Facts & Figures by Country
9.2.1 Asia Pacific Telmisartan Sales by Region (2015-2020)
9.2.2 Asia Pacific Telmisartan Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Telmisartan Market Size YoY Growth 2015-2026
10.2 Latin America Telmisartan Market Facts & Figures by Country
10.2.1 Latin America Telmisartan Sales by Country
10.2.2 Latin America Telmisartan Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Telmisartan Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Telmisartan Market Facts & Figures by Country
11.2.1 Middle East and Africa Telmisartan Sales by Country
11.2.2 Middle East and Africa Telmisartan Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Telmisartan Products Offered
12.1.5 Pfizer Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Telmisartan Products Offered
12.2.5 Teva Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Telmisartan Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Telmisartan Products Offered
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Telmisartan Products Offered
12.5.5 Mylan Recent Development
12.6 Reddy's Laboratories (UK)
12.6.1 Reddy's Laboratories (UK) Corporation Information
12.6.2 Reddy's Laboratories (UK) Description and Business Overview
12.6.3 Reddy's Laboratories (UK) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Reddy's Laboratories (UK) Telmisartan Products Offered
12.6.5 Reddy's Laboratories (UK) Recent Development
12.7 Hema Pharmaceuticals Pvt
12.7.1 Hema Pharmaceuticals Pvt Corporation Information
12.7.2 Hema Pharmaceuticals Pvt Description and Business Overview
12.7.3 Hema Pharmaceuticals Pvt Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hema Pharmaceuticals Pvt Telmisartan Products Offered
12.7.5 Hema Pharmaceuticals Pvt Recent Development
12.8 Bayer
12.8.1 Bayer Corporation Information
12.8.2 Bayer Description and Business Overview
12.8.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bayer Telmisartan Products Offered
12.8.5 Bayer Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Description and Business Overview
12.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GSK Telmisartan Products Offered
12.9.5 GSK Recent Development
12.10 Astellas Pharma Inc
12.10.1 Astellas Pharma Inc Corporation Information
12.10.2 Astellas Pharma Inc Description and Business Overview
12.10.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Astellas Pharma Inc Telmisartan Products Offered
12.10.5 Astellas Pharma Inc Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Telmisartan Products Offered
12.11.5 Pfizer Recent Development
12.12 Abbott
12.12.1 Abbott Corporation Information
12.12.2 Abbott Description and Business Overview
12.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Abbott Products Offered
12.12.5 Abbott Recent Development
12.13 Takeda
12.13.1 Takeda Corporation Information
12.13.2 Takeda Description and Business Overview
12.13.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Takeda Products Offered
12.13.5 Takeda Recent Development
12.14 Beijing Wansheng Pharmaceutical
12.14.1 Beijing Wansheng Pharmaceutical Corporation Information
12.14.2 Beijing Wansheng Pharmaceutical Description and Business Overview
12.14.3 Beijing Wansheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Beijing Wansheng Pharmaceutical Products Offered
12.14.5 Beijing Wansheng Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Telmisartan Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Telmisartan Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Telmisartan Market Segments
Table 2. Ranking of Global Top Telmisartan Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Telmisartan Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Freeze-Dried Powder
Table 6. Global Telmisartan Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Telmisartan Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Telmisartan Sales by Regions 2015-2020 (MT)
Table 9. Global Telmisartan Sales Market Share by Regions (2015-2020)
Table 10. Global Telmisartan Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Telmisartan Sales Forecast by Region (2021-2026) (MT)
Table 12. Global Telmisartan Sales by Manufacturers (2015-2020) (MT)
Table 13. Global Telmisartan Sales Share by Manufacturers (2015-2020)
Table 14. Global Telmisartan Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Telmisartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Telmisartan as of 2019)
Table 16. Telmisartan Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Telmisartan Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Telmisartan Price (2015-2020) (USD/Kg)
Table 19. Telmisartan Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Telmisartan Product Type
Table 21. Date of International Manufacturers Enter into Telmisartan Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Telmisartan Sales by Type (2015-2020) (MT)
Table 24. Global Telmisartan Sales Share by Type (2015-2020)
Table 25. Global Telmisartan Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Telmisartan Revenue Share by Type (2015-2020)
Table 27. Telmisartan Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 28. Global Telmisartan Sales Share by Type (2021-2026)
Table 29. Global Telmisartan Sales by Application (2015-2020) (MT)
Table 30. Global Telmisartan Sales Share by Application (2015-2020)
Table 31. Global Telmisartan Sales Share by Application (2021-2026)
Table 32. Global Telmisartan Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Telmisartan Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Telmisartan Revenue Market Share Forecast by Application (2021-2026)
Table 35. United States Telmisartan Sales (MT) of Key Companies (2015-2020)
Table 36. United States Telmisartan Sales Share by Company (2015-2020)
Table 37. United States Telmisartan Revenue (US$ Million) by Company (2015-2020)
Table 38. United States Telmisartan Sales (MT) by Type (2015-2020)
Table 39. United States Telmisartan Sales Share by Type (2015-2020)
Table 40. United States Telmisartan Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. United States Telmisartan Price (MT) by Type (2015-2020)
Table 42. United States Telmisartan Sales (MT) by Type (2021-2026)
Table 43. United States Telmisartan Sales Share by Type (2021-2026)
Table 44. United States Telmisartan Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. United States Telmisartan Revenue Share by Type (2021-2026)
Table 46. United States Telmisartan Price (MT) by Type (2021-2026)
Table 47. United States Telmisartan Sales (MT) by Application (2015-2020)
Table 48. United States Telmisartan Sales Share by Application (2015-2020)
Table 49. United States Telmisartan Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. United States Telmisartan Sales (MT) by Application (2021-2026)
Table 51. United States Telmisartan Sales Share by Application (2021-2026)
Table 52. United States Telmisartan Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. United States Telmisartan Revenue Share by Application (2021-2026)
Table 54. North America Telmisartan Sales by Country (2015-2020) (MT)
Table 55. North America Telmisartan Sales Market Share by Country (2015-2020)
Table 56. North America Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Telmisartan Revenue Market Share by Country (2015-2020)
Table 58. Europe Telmisartan Sales by Country (2015-2020) (MT)
Table 59. Europe Telmisartan Sales Market Share by Country (2015-2020)
Table 60. Europe Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Telmisartan Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Telmisartan Sales by Region (2015-2020) (MT)
Table 63. Asia Pacific Telmisartan Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Telmisartan Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Telmisartan Revenue Market Share by Region (2015-2020)
Table 66. Latin America Telmisartan Sales by Country (2015-2020) (MT)
Table 67. Latin America Telmisartan Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Telmisartan Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Telmisartan Sales by Country (2015-2020) (MT)
Table 71. Middle East and Africa Telmisartan Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Telmisartan Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Telmisartan Revenue Market Share by Country (2015-2020)
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Pfizer Telmisartan Product
Table 78. Pfizer Recent Development
Table 79. Teva Corporation Information
Table 80. Teva Description and Business Overview
Table 81. Teva Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Teva Product
Table 83. Teva Recent Development
Table 84. Boehringer Ingelheim Corporation Information
Table 85. Boehringer Ingelheim Description and Business Overview
Table 86. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Boehringer Ingelheim Product
Table 88. Boehringer Ingelheim Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Business Overview
Table 91. Novartis Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Mylan Corporation Information
Table 95. Mylan Description and Business Overview
Table 96. Mylan Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Mylan Product
Table 98. Mylan Recent Development
Table 99. Reddy's Laboratories (UK) Corporation Information
Table 100. Reddy's Laboratories (UK) Description and Business Overview
Table 101. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Reddy's Laboratories (UK) Product
Table 103. Reddy's Laboratories (UK) Recent Development
Table 104. Hema Pharmaceuticals Pvt Corporation Information
Table 105. Hema Pharmaceuticals Pvt Description and Business Overview
Table 106. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Hema Pharmaceuticals Pvt Product
Table 108. Hema Pharmaceuticals Pvt Recent Development
Table 109. Bayer Corporation Information
Table 110. Bayer Description and Business Overview
Table 111. Bayer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Bayer Product
Table 113. Bayer Recent Development
Table 114. GSK Corporation Information
Table 115. GSK Description and Business Overview
Table 116. GSK Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. GSK Product
Table 118. GSK Recent Development
Table 119. Astellas Pharma Inc Corporation Information
Table 120. Astellas Pharma Inc Description and Business Overview
Table 121. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Astellas Pharma Inc Product
Table 123. Astellas Pharma Inc Recent Development
Table 124. Nippon Boehringer Ingelheim Corporation Information
Table 125. Nippon Boehringer Ingelheim Description and Business Overview
Table 126. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Nippon Boehringer Ingelheim Product
Table 128. Nippon Boehringer Ingelheim Recent Development
Table 129. Abbott Corporation Information
Table 130. Abbott Description and Business Overview
Table 131. Abbott Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Abbott Product
Table 133. Abbott Recent Development
Table 134. Takeda Corporation Information
Table 135. Takeda Description and Business Overview
Table 136. Takeda Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 137. Takeda Product
Table 138. Takeda Recent Development
Table 139. Beijing Wansheng Pharmaceutical Corporation Information
Table 140. Beijing Wansheng Pharmaceutical Description and Business Overview
Table 141. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 142. Beijing Wansheng Pharmaceutical Product
Table 143. Beijing Wansheng Pharmaceutical Recent Development
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Telmisartan Players
Table 148. Telmisartan Customers List
Table 149. Telmisartan Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Telmisartan Product Picture
Figure 2. Global Telmisartan Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Freeze-Dried Powder Product Picture
Figure 5. Global Telmisartan Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Use
Figure 7. Clinic Use
Figure 8. Others
Figure 9. Telmisartan Report Years Considered
Figure 10. Global Telmisartan Market Size 2015-2026 (US$ Million)
Figure 11. Global Telmisartan Sales 2015-2026 (MT)
Figure 12. Global Telmisartan Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Telmisartan Sales Market Share by Region (2015-2020)
Figure 14. Global Telmisartan Sales Market Share by Region in 2019
Figure 15. Global Telmisartan Revenue Market Share by Region (2015-2020)
Figure 16. Global Telmisartan Revenue Market Share by Region in 2019
Figure 17. Global Telmisartan Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Telmisartan Revenue in 2019
Figure 19. Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Telmisartan Sales Market Share by Type (2015-2020)
Figure 21. Global Telmisartan Sales Market Share by Type in 2019
Figure 22. Global Telmisartan Revenue Market Share by Type (2015-2020)
Figure 23. Global Telmisartan Revenue Market Share by Type in 2019
Figure 24. Global Telmisartan Market Share by Price Range (2015-2020)
Figure 25. Global Telmisartan Sales Market Share by Application (2015-2020)
Figure 26. Global Telmisartan Sales Market Share by Application in 2019
Figure 27. Global Telmisartan Revenue Market Share by Application (2015-2020)
Figure 28. Global Telmisartan Revenue Market Share by Application in 2019
Figure 29. United States Telmisartan Sales Growth Rate 2015-2026 (MT)
Figure 30. United States Telmisartan Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. United States Telmisartan Market Share in Global Market 2015-2026
Figure 32. United States 5 and 10 Largest Telmisartan Players Market Share by Revenue in Telmisartan in 2019
Figure 33. United States Telmisartan Revenue Share by Type (2015-2020)
Figure 34. United States Telmisartan Revenue Growth Rate by Type in 2015 & 2019
Figure 35. United States Telmisartan Revenue Share by Application (2015-2020)
Figure 36. United States Telmisartan Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 38. North America Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Telmisartan Sales Market Share by Country in 2019
Figure 40. North America Telmisartan Revenue Market Share by Country in 2019
Figure 41. U.S. Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 42. U.S. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 44. Canada Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 46. Europe Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Telmisartan Sales Market Share by Country in 2019
Figure 48. Europe Telmisartan Revenue Market Share by Country in 2019
Figure 49. Germany Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 50. Germany Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 52. France Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 54. U.K. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 56. Italy Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 58. Russia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 60. Asia Pacific Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Telmisartan Sales Market Share by Region in 2019
Figure 62. Asia Pacific Telmisartan Revenue Market Share by Region in 2019
Figure 63. China Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 64. China Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 66. Japan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 68. South Korea Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 70. India Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 72. Australia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 74. Taiwan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 76. Indonesia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 78. Thailand Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 80. Malaysia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 82. Philippines Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 84. Vietnam Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Telmisartan Sales Market Share by Country in 2019
Figure 88. Latin America Telmisartan Revenue Market Share by Country in 2019
Figure 89. Mexico Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Telmisartan Sales Growth Rate 2015-2020 (MT)
Figure 96. Middle East and Africa Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Telmisartan Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Telmisartan Revenue Market Share by Country in 2019
Figure 99. Turkey Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 100. Turkey Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 102. Saudi Arabia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Telmisartan Sales Growth Rate (2015-2020) (MT)
Figure 104. U.A.E Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Telmisartan Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs